Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses. This is an ADR of a company whose stock trades outside of the U.S. as the symbol SM:GRF.P .
$8.66 -0.18 (-2.04%)
As of 08/17/2022 15:59:57 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.